论文部分内容阅读
目的探讨支气管扩张剂氧驱动雾化吸入辅助治疗小婴儿毛细支气管炎的疗效。方法将2010年10月至2013年10月收治的诊断为毛细支气管炎的286例患儿按治疗方法不同分为治疗组和对照组,两组均采用相同的基础治疗。治疗组用复方异丙托溴胺溶液雾化吸入辅助治疗,对照组用沙丁胺醇雾化吸入辅助治疗。对两组主要症状、体征消失时间、住院天数和总有效率进行对比。结果治疗组在主要症状、改善体征、住院天数、总有效率方面均优于对照组(P<0.05)。结论雾化吸入支气管扩张剂能快速缓解患儿的症状、体征,缩短住院时间,提高治愈率,是一种方便、有效、安全的用药方案。
Objective To investigate the efficacy of bronchodilator oxygen-driven nebulization in the treatment of bronchiolitis in infants. Methods A total of 286 children with bronchiolitis diagnosed from October 2010 to October 2013 were divided into treatment group and control group according to different treatment methods. The same basic treatment was used in both groups. The treatment group was treated with compound ipratropium bromide aerosol inhalation adjuvant therapy, while the control group was treated with salbutamol inhalation. The main symptoms of the two groups, the disappearance of signs, days of hospitalization and total effective rate were compared. Results The treatment group was better than the control group in the main symptoms, signs of improvement, days of hospitalization, and total effective rate (P <0.05). Conclusion inhalation of bronchodilator can quickly alleviate the symptoms and signs of children, shorten the hospital stay and improve the cure rate, is a convenient, effective and safe drug program.